THE DEAL, AT A GLANCE
From the announcementEnveda Biosciences
01Who is involvedBacked by Obvious, DigitalisFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedEnveda Biosciences raised $51M Series BFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersEnveda Biosciences' $51M Series B positions the company as a mid-market Healthcare & Life Sciences financing in an active funding tape, with sector capital formation…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Enveda Biosciences · Financing Record
Explore source-linked visual explanations for Enveda Biosciences. Unsupported claims are withheld while source review continues.
Record 866 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →